Skip to main content

Invitrogen Licenses Gene-Delivery Technology from Cell Genesys

NEW YORK, Aug. 10 – Invitrogen has exclusively licensed lentiviral gene-delivery technology from Cell Genesys for use in gene-expression research and drug-target validation, the companies said on Friday. 

The agreement grants San Diego-based Invitrogen worldwide rights to sell kits, products, and services using the lentiviral-vector technology. In return, Invitrogen will pay Cell Genesys royalties on any sales, as well as a portion of fees generated from sublicensing the technology to companies applying the technology to commercial bioprocessing or in their own products.

Lentiviral gene delivery is one technique for modifying a cell or organism’s DNA by delivering genetic information directly into a cell’s nucleus. The method is particularly useful for gene expression and drug-target validation studies in non-dividing or slowly dividing cells, the companies said in a statement.

Cell Genesys, based in Foster City, Calif., is developing cancer vaccines and gene-therapy techniques for treating major diseases. For applications outside of this focus, the company is seeking partners to license its gene-delivery intellectual property.

Last week, Cell Genesys acquired Calydon, a Sunnyvale, Calif.-based biotechnology company focused on developing therapeutic products for cancer. Cell Genesys also holds a 10.5 percent stake in antibody manufacturer Abgenix, based in Fremont, Calif.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.